Dr. Bilal Hameed, MD

Dr. Hameed practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Hameed's NPI, 1114037421, was assigned on August 30, 2006. Dr. Hameed graduated from Dow University of Health Sciences in 2000. Dr. Hameed holds California license A109128.

Dr. Hameed's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Hameed's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Hameed is also affiliated with MarinHealth Medical Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Hameed to 2 more hospitals, 4 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hameed practices, 8 sites in all. Vendor and product names are available with a free account.

Transplant hepatology is Dr. Hameed's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Dr. Hameed is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Hameed's licenses on file in 3 states: California, Nevada and Minnesota.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis, cirrhosis of the liver, fatty liver, hepatitis c and upper GI endoscopy among the conditions Dr. Hameed treats.

CMS data shows 628 Medicare services from Dr. Hameed across 7 procedure codes in 2024, for 222 Medicare patients. Medicare paid $46,011 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 222 Medicare patients who saw Dr. Hameed in 2024. The largest group is 65 to 74, with 134 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hameed's median patient age at 61, with 51% women.

In 2024, Dr. Hameed wrote 372 Medicare Part D claims for 74 patients. 87% of them were for generic drugs. CMS names the drug for 303 of them, across 12 drugs with 11 or more claims each, at $93,431 in total drug cost. In 2023, CMS named 238 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Hameed for performance year 2024, reported as part of a group. Dr. Hameed accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hameed as offering telehealth.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 102 papers to Dr. Hameed, published from 2008 to 2025. 2021 was the busiest year, with 16. The most frequent topics are Liver Transplantation, Liver Cirrhosis and Kidney Calculi. Dr. Hameed has published most often in J Endourol. Dr. Hameed's most frequent co-authors are Bilal Hameed, MD, Milap Shah, DO and William Martens Lee, MD.

Dmand AI links Dr. Hameed to 3 clinical trials. 3 are still active or recruiting. Conditions studied include Liver Cirrhosis, Alcoholic, Cirrhosis, Cryptogenic and Non-alcoholic Fatty Liver Disease.

CMS Open Payments shows 58 general payments to Dr. Hameed from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 61% of the total. Gilead Sciences, Inc. paid the most, $33,810.

Dmand AI lists 1 award for Dr. Hameed, most recently CMS Stage 1 EHR in 2013.

Dr. Hameed graduated from Dow University of Health Sciences in 2000.

Dr. Hameed is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.